ReviewArchives of microbiology2026
Endophytic nanotechnology as a dual-action approach against agricultural and clinical fungal pathogens.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sustainable synthesis of mono-, bi- and tri-metallic nanoparticles using endophytic fungi: characterization and different applications.RSC advances · 2026Review
- Green-Synthesized vs. Chemical Silver Nanoparticles: A Comparative Study onMicroorganisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal infections are rapidly emerging as a serious global concern, impacting both the agriculture and healthcare sectors. While fungi play essential roles in geochemical cycles, certain species have become significant threats to human health and agricultural productivity. The rise of resistant and opportunistic fungal pathogens has led to increased mortality rates in humans and severe crop losses. It draws scientific attention to the urgent need for sustainable alternatives of antifungals. The growing resistance in fungal strains has further intensified the innovation in antifungal strategies. Existing antifungal agents are limited in scope and efficacy, particularly against resistant strains. In this context, endophytic nanotechnology offers a promising solution. Endophyte derived nanoparticles present a sustainable, eco-friendly, and effective strategy to combat fungal infections. This review comprehensively discusses the role of endophyte derived nanoparticles in addressing fungal diseases in both agriculture and healthcare. It also highlights the biosynthesis mechanisms, modes of antifungal action, and key studies demonstrating the efficacy of endophyte-mediated nanoparticles. This emerging technology provides a valuable foundation for the development of next-generation antifungal agents with enhanced specificity, reduced toxicity, and minimal environmental impact. By integrating microbiology, nanoscience, and biotechnology, endophytic nanotechnology emerges as a dual-action, eco-friendly, and effective strategy for managing fungal infections across agricultural and clinical domains.
Indexed as
Identifiers
41493460What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.